Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 73801 - 73825 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Silicon dioxide	Approved	ZNF768	79724	upregulated	Silicon Dioxide analog results in increased expression of ZNF768 mRNA	16p11.2	A24194
Silicon dioxide	Approved	ZNF770	54989	downregulated	Silicon Dioxide results in decreased expression of ZNF770 mRNA	15q14	A24196
Silicon dioxide	Approved	ZNF783	100289678	downregulated	Silicon Dioxide results in decreased expression of ZNF783 mRNA	7q36.1	A24196
Silicon dioxide	Approved	ZNF804A	91752	downregulated	Silicon Dioxide analog results in decreased expression of ZNF804A mRNA	2q32.1	A24195
Silicon dioxide	Approved	ZNF827	152485	downregulated	Silicon Dioxide analog results in decreased expression of ZNF827 mRNA	4q31.21-q31.22	A24195
Silicon dioxide	Approved	ZNF829	374899	downregulated	Silicon Dioxide analog results in decreased expression of ZNF829 mRNA	19q13.12	A24195
Silicon dioxide	Approved	ZNF862	643641	downregulated	Silicon Dioxide analog results in decreased expression of ZNF862 mRNA	7q36.1	A24195
Silicon dioxide	Approved	ZNF92	168374	downregulated	Silicon Dioxide analog results in decreased expression of ZNF92 mRNA	7q11.21	A24195
Silicon dioxide	Approved	ZNF93	81931	upregulated	Silicon Dioxide results in increased expression of ZNF93 mRNA	19p12	A24196
Silicon dioxide	Approved	ZNRD1ASP	80862	downregulated	Silicon Dioxide results in decreased expression of ZNRD1ASP mRNA	6p22.1	A24196
Silicon dioxide	Approved	ZNRF2P1	441208	upregulated	Silicon Dioxide analog results in increased expression of ZNRF2P1 mRNA	7p14.3	A24195
Silicon dioxide	Approved	ZNRF3	84133	downregulated	Silicon Dioxide analog results in decreased expression of ZNRF3 mRNA	22q12.1	A24195
Silicon dioxide	Approved	ZP1	22917	downregulated	Silicon Dioxide analog results in decreased expression of ZP1 mRNA	11q12.2	A24195
Silicon dioxide	Approved	ZPBP	11055	upregulated	Silicon Dioxide analog results in increased expression of ZPBP mRNA	7p12.2	A24195
Silicon dioxide	Approved	ZSCAN12	9753	downregulated	Silicon Dioxide results in decreased expression of ZSCAN12 mRNA	6p22.1	A24196
Silicon dioxide	Approved	ZSCAN32	54925	downregulated	Silicon Dioxide results in decreased expression of ZSCAN32 mRNA	16p13.3	A24196
Silicon dioxide	Approved	ZSWIM5	57643	downregulated	Silicon Dioxide analog results in decreased expression of ZSWIM5 mRNA	1p34.1	A24195
Silicon dioxide	Approved	ZWILCH	55055	downregulated	Silicon Dioxide results in decreased expression of ZWILCH mRNA	15q22.31	A24196
Silicon dioxide	Approved	ZWINT	11130	downregulated	Silicon Dioxide analog results in decreased expression of ZWINT mRNA	10q21-q22	A24194
Silver	Approved Investigational	ACTG2	72	downregulated	Silver analog results in decreased expression of ACTG2 mRNA	2p13.1	A24215
Silver	Approved Investigational	ADAM9	8754	upregulated	Silver results in increased expression of ADAM9 mRNA	8p11.22	A24216
Silver	Approved Investigational	ADAMTS1	9510	upregulated	Silver results in increased expression of ADAMTS1 mRNA	21q21.3	A24216
Silver	Approved Investigational	ADAMTS9	56999	downregulated	Silver results in decreased expression of ADAMTS9 mRNA	3p14.1	A24216
Silver	Approved Investigational	ADORA2A	135	downregulated	Silver results in decreased expression of ADORA2A mRNA	22q11.23	A24217
Silver	Approved Investigational	ADORA3	140	downregulated	Silver results in decreased expression of ADORA3 mRNA	1p13.2	A24216

Displaying entries 73801 - 73825 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability